A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Clinical trial NCT06047548 · COMPLETED
Trial details
- NCT number
- NCT06047548
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-20
- Primary completion
- 2026-01-20
- Enrollment
- 441
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.